These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21710976)

  • 1. Synthesis and biological evaluation of a polyglutamic acid-dopamine conjugate: a new antiangiogenic agent.
    Fante C; Eldar-Boock A; Satchi-Fainaro R; Osborn HM; Greco F
    J Med Chem; 2011 Jul; 54(14):5255-9. PubMed ID: 21710976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.
    Czakó B; Kürti L; Mammoto A; Ingber DE; Corey EJ
    J Am Chem Soc; 2009 Jul; 131(25):9014-9. PubMed ID: 19469509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic potency of vitamin E.
    Miyazawa T; Tsuzuki T; Nakagawa K; Igarashi M
    Ann N Y Acad Sci; 2004 Dec; 1031():401-4. PubMed ID: 15753181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M; Alsmadi O; Al-Mohanna F
    Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
    Haviv F; Bradley MF; Kalvin DM; Schneider AJ; Davidson DJ; Majest SM; McKay LM; Haskell CJ; Bell RL; Nguyen B; Marsh KC; Surber BW; Uchic JT; Ferrero J; Wang YC; Leal J; Record RD; Hodde J; Badylak SF; Lesniewski RR; Henkin J
    J Med Chem; 2005 Apr; 48(8):2838-46. PubMed ID: 15828822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic properties of gold nanoparticles.
    Mukherjee P; Bhattacharya R; Wang P; Wang L; Basu S; Nagy JA; Atala A; Mukhopadhyay D; Soker S
    Clin Cancer Res; 2005 May; 11(9):3530-4. PubMed ID: 15867256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced thyme product prevents VEGF-induced migration in human umbilical vein endothelial cells.
    Krill D; Madden J; Huncik K; Moeller PD
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):275-81. PubMed ID: 21073864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis.
    Pourgholami MH; Khachigian LM; Fahmy RG; Badar S; Wang L; Chu SW; Morris DL
    Biochem Biophys Res Commun; 2010 Jul; 397(4):729-34. PubMed ID: 20537982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.
    Ito Y; Oike Y; Yasunaga K; Hamada K; Miyata K; Matsumoto S; Sugano S; Tanihara H; Masuho Y; Suda T
    Cancer Res; 2003 Oct; 63(20):6651-7. PubMed ID: 14583458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
    Goncalves V; Gautier B; Coric P; Bouaziz S; Lenoir C; Garbay C; Vidal M; Inguimbert N
    J Med Chem; 2007 Oct; 50(21):5135-46. PubMed ID: 17900101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo.
    Basile A; Del Gatto A; Diana D; Di Stasi R; Falco A; Festa M; Rosati A; Barbieri A; Franco R; Arra C; Pedone C; Fattorusso R; Turco MC; D'Andrea LD
    J Med Chem; 2011 Mar; 54(5):1391-400. PubMed ID: 21280635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
    Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors.
    Potashman MH; Bready J; Coxon A; DeMelfi TM; DiPietro L; Doerr N; Elbaum D; Estrada J; Gallant P; Germain J; Gu Y; Harmange JC; Kaufman SA; Kendall R; Kim JL; Kumar GN; Long AM; Neervannan S; Patel VF; Polverino A; Rose P; Plas Sv; Whittington D; Zanon R; Zhao H
    J Med Chem; 2007 Sep; 50(18):4351-73. PubMed ID: 17696416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic activity of Diallyl Sulfide (DAS).
    Thejass P; Kuttan G
    Int Immunopharmacol; 2007 Mar; 7(3):295-305. PubMed ID: 17276887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of angiogenesis by the plant alkaloid, sanguinarine.
    Eun JP; Koh GY
    Biochem Biophys Res Commun; 2004 Apr; 317(2):618-24. PubMed ID: 15063803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.